Showing results (801-810 of 1,019) with videos related to

Sort By:
Pageof 102
Clinicoeconomics and Outcomes Research : CEOR|September 22, 2021
Cost-Effectiveness of a Proteomic Test for Preterm Birth PredictionMichael Grabner, Julja Burchard, Chi Nguyen, et al.
Clinicoeconomics and Outcomes Research : CEOR|April 15, 2022
Cost Analysis of Platelet Transfusion in Italy for Patients with Chronic Liver Disease and Associated Thrombocytopenia Undergoing Elective ProceduresGiulia Mastrorilli, Francesca Fiorentino, Carmen Tucci, et al.
Clinicoeconomics and Outcomes Research : CEOR|November 15, 2023
Estimating the Cost of Spinopelvic Complications After Adult Spinal Deformity SurgeryScott L Zuckerman, Daniel Cher, Robyn Capobianco, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 23, 2023
Cost-Effectiveness of Acthar Gel versus Standard of Care for the Treatment of Advanced Symptomatic SarcoidosisJas Bindra, Ishveen Chopra, Kyle Hayes, et al.
Clinicoeconomics and Outcomes Research : CEOR|October 5, 2023
Examining the Burden of Potentially Avoidable Heart Failure HospitalizationsMarya D Zilberberg, Brian H Nathanson, Kate Sulham, et al.
Clinicoeconomics and Outcomes Research : CEOR|July 10, 2023
Clinical and Economic Burden Associated with Disruptive Surgical Bleeding: A Retrospective Database AnalysisStephen S Johnston, Mosadoluwa Afolabi, Pranjal Tewari, et al.
Clinicoeconomics and Outcomes Research : CEOR|July 5, 2023
Eleven-Year Trends in Lipid-Modifying Medicines Utilisation and Expenditure in a Low-Income Country: A Study from the Republic of Srpska, Bosnia and HerzegovinaDragan Kalinić, Ranko Škrbić, Duško Vulić, et al.
Clinicoeconomics and Outcomes Research : CEOR|June 27, 2023
Effectiveness of Disinfecting Caps for Intravenous Access Points in Reducing Central Line-Associated Bloodstream Infections, Clinical Utilization, and Cost of Care During COVID-19Yuefeng Hou, Leah P Griffin, Kari Ertmer, et al.
Clinicoeconomics and Outcomes Research : CEOR|December 7, 2019
Budget Impact Of Including Avelumab As A Second-Line Treatment For Locally Advanced Or Metastatic Urothelial Cancer In The United States: Commercial And Medicare Payer PerspectivesThitima Kongnakorn, Murtuza Bharmal, Mairead Kearney, et al.
Clinicoeconomics and Outcomes Research : CEOR|December 12, 2019
Real-World Economic Outcomes of Brexpiprazole and Extended-Release Quetiapine Adjunctive Use in Major Depressive DisorderArpamas Seetasith, Mallik Greene, Ann Hartry, et al.
Pageof 102